Tonmya FDA Approval Status
FDA Approved: No
Brand name: Tonmya
Generic name: cyclobenzaprine hydrochloride
Previous Name: TNX-102
Company: Tonix Pharmaceuticals Holding Corp.
Treatment for: Post Traumatic Stress Disorder
Tonmya (cyclobenzaprine) is a sublingual formulation of an approved skeletal muscle relaxant in development for the treatment of patients with post-traumatic stress disorder (PTSD).
Development timeline for Tonmya
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.